Relapse Mechanism and Treatment Strategy After Chimeric Antigen Receptor T-Cell Therapy in Treating B-Cell Hematological Malignancies

Danni Xie(Tianjin Medical University), Mingfeng Zhao(Nankai University), Xia Xiong(Chinese Academy of Sciences), Meng Zhang(Scripps Research Institute), Jiaxi Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Rui Sun(Tianjin Medical University Eye Hospital), Xiaomei Zhang(Tang Hospital), Xin Jin(Nankai University)
Technology in Cancer Research & Treatment
January 1, 2022
10.1177/15330338221118413
Cited by 9

Related Papers

Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages
|Theranostics|2020|397
A RORγt+ cell instructs gut microbiota-specific Treg cell differentiation
|Nature|2022|253
First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
|Journal of Hematology & Oncology|2022|149
ROS-mediated iron overload injures the hematopoiesis of bone marrow by damaging hematopoietic stem/progenitor cells in mice
|Scientific Reports|2015|143
Effects of Fermented Milk Containing Lacticaseibacillus paracasei Strain Shirota on Constipation in Patients with Depression: A Randomized, Double-Blind, Placebo-Controlled Trial
|Nutrients|2021|134